Does TARLATAMAB-DLLE Cause Confusional state? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Confusional state have been filed in association with TARLATAMAB-DLLE (IMDELLTRA (AMG757)). This represents 1.7% of all adverse event reports for TARLATAMAB-DLLE.
14
Reports of Confusional state with TARLATAMAB-DLLE
1.7%
of all TARLATAMAB-DLLE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Confusional state From TARLATAMAB-DLLE?
Of the 14 reports, 6 (42.9%) required hospitalization, and 2 (14.3%) were considered life-threatening.
Is Confusional state Listed in the Official Label?
Yes, Confusional state is listed as a known adverse reaction in the official FDA drug label for TARLATAMAB-DLLE.
What Other Side Effects Does TARLATAMAB-DLLE Cause?
Cytokine release syndrome (274)
Immune effector cell-associated neurotoxicity syndrome (127)
Off label use (111)
Pyrexia (75)
Small cell lung cancer (66)
Death (45)
Disease progression (34)
Metastases to central nervous system (28)
Decreased appetite (23)
Dysgeusia (22)
What Other Drugs Cause Confusional state?
METHOTREXATE (4,962)
ACETAMINOPHEN (4,630)
OXYCODONE (4,599)
PREDNISONE (4,441)
ADALIMUMAB (4,399)
RITUXIMAB (4,020)
TOCILIZUMAB (3,949)
ABATACEPT (3,879)
LEFLUNOMIDE (3,795)
PIMAVANSERIN (3,779)
Which TARLATAMAB-DLLE Alternatives Have Lower Confusional state Risk?
TARLATAMAB-DLLE vs TASIGNA
TARLATAMAB-DLLE vs TASIMELTEON
TARLATAMAB-DLLE vs TAVABOROLE
TARLATAMAB-DLLE vs TAXOL
TARLATAMAB-DLLE vs TAXOTERE